{"SPADE_N_03131": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2008/0125359 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2008_0125359_A1", "Patent Type": "Patent Application", "Publication Date": "2008-5-29", "Family Info": "US7465784,US7985836,US20090156499,US20110251120", "Patent Title": "Antimicrobial peptides and methods of identifying the same.", "Abstract": "Antimicrobial peptides and methods of identifying the same are provided."}], "Sequence Information": {"SPADE ID": "SPADE_N_03131", "Peptide Name": "LL-37(17-32)(C-terminal fragment of LL-37; Human, mammals, animals)", "Source": "Homo sapiens (Human)", "Family": "Not found", "Gene": "Not found", "Sequence": "FKRIVQRIKDFLRNLV", "Sequence Length": 16, "UniProt Entry": ["http://www.uniprot.org/uniprot/P49913", "http://www.uniprot.org/uniprot/Q71SN9"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram-", "Anticancer"], "Target Organism": "Gram-negative bacteria:Escherichia coli K12(MIC=20 µM).Drug-resistant KBv cancer cells (LC50=30 µM), Drug-sensitive KB cancer cells (LC50=30 µM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "To achieve selective membrane targeting, D-amino acids were incorporated into LL-37(17-32). The D-peptide showed similar antibacterial activity to the L-diastereomer, it lost toxicity to human cells.", "Formula": "C95H161N29O21", "Mass": 2045.48, "PI": 11.72, "Net Charge": 4, "Hydrophobicity": -0.08, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Comments": "Antibacterial and anticancer assays found that LL-37(17-32) was more active than LL-37(13-37).", "Literature": [{"Title": "Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.", "Pubmed ID": "16637646", "Reference": "J Am Chem Soc. 2006 May 3;128(17)5776-5785.", "Author": "Li X, Li Y, Han H, Miller DW, Wang G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16637646"}], "Frequent Amino Acids": "RFI", "Absent Amino Acids": "ACEGHMOPSTUWY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02277", "Similarity": 1.0, "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"}, {"SPADE_ID": "SPADE_N_02334", "Similarity": 1.0, "Sequence": "LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES"}, {"SPADE_ID": "SPADE_N_03100", "Similarity": 1.0, "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"}]}}}